Header Logo

Connection

DOV KADMON to Risk

Back to Details
This is a "connection" page, showing publications DOV KADMON has written about Risk.
DOV KADMON
Connection Strength
0.083
Risk
  1. GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy. Clin Cancer Res. 2011 Nov 15; 17(22):7174-82.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.